Author's Reply

Affiliations

• ¹ Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ² Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Cecil G. Sheps Center for Health Services Research, Chapel Hill, NC, USA.
• ³ Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, USA.
• ⁴ Division of Hematology and Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
• ⁵ Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. Electronic address: s.dusetzina@vanderbilt.edu.